20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with Diabetic Glomerulosclerosis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Azar, ST; Azar, TS; Azar, WS; Eid, AA; Hamdy, AF; Houeiss, P; Njeim, R; Noureldein, M; Rashid, A; Tamim, H; Zeidan, YH | 1 |
| Chen, R; Cheng, O; Ding, S; Huang, B; Huang, J; Jiang, Q; Qiu, H; Zhang, J; Zou, X | 1 |
| Chen, R; Cheng, O; Ding, S; Huang, B; Huang, J; Jiang, Q; Qiu, H; Zhang, J | 1 |
| Eid, AA; Eid, S; Hamdy, A; Jaffa, AA; Maalouf, R; Nassif, J; Rashid, A; Ziyadeh, FN | 1 |
| Capdevila, JH; Falck, JR; Gangadhariah, MH; Garcia, V; Hayward, SW; Imig, JD; Love, HD; Luther, JM; Manthati, VL; Paueksakon, P; Pozzi, A; Schwartzman, ML; Zent, R; Zhang, MZ | 1 |
| Chang, HH; Inscho, EW; Luo, P; Seki, T; Wang, CY; Wang, MH; Zhang, J; Zhou, Y | 1 |
6 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Urinary 20-HETE: A prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney disease.
Topics: Diabetes Mellitus; Diabetic Nephropathies; Humans; Kidney; Prognosis; Prospective Studies | 2023 |
Activation of 20-HETE/PPARs involved in reno-therapeutic effect of naringenin on diabetic nephropathy.
Topics: Animals; Cell Line; Cell Proliferation; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, High-Fat; Female; Flavanones; Glucose; Hydroxyeicosatetraenoic Acids; Kidney; Mice; Peroxisome Proliferator-Activated Receptors; Rats; Streptozocin; Up-Regulation | 2019 |
Effects of PPARs/20-HETE on the renal impairment under diabetic conditions.
Topics: Amidines; Anilides; Animals; Cell Line; Cytochrome P-450 CYP4A; Diabetic Nephropathies; Down-Regulation; Epithelial Cells; Gene Expression Regulation; Glucose; Hydroxyeicosatetraenoic Acids; Indoles; Kidney Tubules; Male; Mice; PPAR alpha; PPAR gamma; PPAR-beta; Rats; Sulfones; Thiophenes | 2019 |
20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathway.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Blotting, Western; Cells, Cultured; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Diabetic Nephropathies; Glucose; Hydroxyeicosatetraenoic Acids; Hypertrophy; Kidney Tubules, Proximal; Oxidative Stress; Rats; Reactive Oxygen Species; Ribosomal Protein S6 Kinases, 70-kDa; TOR Serine-Threonine Kinases | 2013 |
Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy.
Topics: Animals; Collagen; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 4; Diabetic Nephropathies; Glomerular Basement Membrane; Hydralazine; Hydrochlorothiazide; Hydroxyeicosatetraenoic Acids; Hypertension; Male; Mice, Knockout; Orchiectomy; Renin-Angiotensin System; Reserpine; Sodium | 2015 |
Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy.
Topics: 8,11,14-Eicosatrienoic Acid; Amino Acids; Animals; Clofibrate; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epoxide Hydrolases; Epoxy Compounds; Hydroxyeicosatetraenoic Acids; Hyperglycemia; Hyperlipidemias; Kidney; Kidney Glomerulus; Male; Polymerase Chain Reaction; Protein Isoforms; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Circulation; Streptozocin; Transforming Growth Factor beta1 | 2009 |